Delcath Systems, Inc retweeted
We presented analysis of patients treated with #ChemoSat (#Hepzato) for breast cancer liver metastases (BCLMs) in European #PHP centres at ESMO Breast Conference this year. Not surprising that BCLMs respond to high dose Melphalan, which is an alkylating agent. @DelcathSystems
Delcath Systems, Inc retweeted
Congratulations to @MoffittNews on completing its 100th HEPZATO KIT® procedure for patients with metastatic uveal melanoma!
Milestones like this reflect growing experience and expanded treatment options for the OM community.
#UvealMelanoma #OcularMelanoma
Delcath Systems, Inc retweeted
Congratulations to Massachusetts General Hospital on completing its 100th HEPZATO KIT procedure!
This milestone highlights the continued growth of liver-directed treatment programs serving patients with metastatic uveal melanoma.
#UvealMelanoma #OcularMelanoma
Delcath Systems, Inc retweeted
Completed our 100th PHP today post FDA approval . A huge thanks to Delcath, bigger thanks to our incredible team here both in IR and Cutaneous oncology, and lastly, thanks to the patients that trusted us to give them the best care for metastatic UM. @DelcathSystems @MoffittNews
Delcath Systems, Inc retweeted
Our newest Animated Patient Video resource for the CURE OM community entitled, "Understanding Metastatic Uveal Melanoma", provides an overview of how metastatic uveal melanoma is diagnosed and treated. Related to treatment, this video series explores the role and importance of HLA testing and treatment options including systemic therapies, liver-directed treatments and clinical trials.
The series also includes wonderful OM patient testimonials such as this clip from Ashley McCrary who shares advice to others navigating their metastatic uveal melanoma journey and the organization she runs known as the Eye on Grace Foundation which helps fund treatment-related travel for those diagnosed with OM.
Watch Ashley's video and other modules as part of our newest Animated Patient video, here - youandmelanoma.com/en-mn/vie…
Delcath Systems, Inc retweeted
💙 Did you know?
A Cure In Sight is the only OM nonprofit offering financial aid for medical bills & living expenses to qualifying patients. 👁️✨
💙 Support this work: acureinsight.org/donate/
#ACureInSight #OcularMelanoma #PatientSupport #RareDisease
Delcath Systems, Inc retweeted
CHEMOSAT and HEPZATO KIT Gain Recognition in Global Guidelines for Metastatic Uveal Melanoma Treatment
Read More Here- acureinsight.org/liver-direc…














